Invention Grant
- Patent Title: MCL-1 inhibitors
-
Application No.: US16410457Application Date: 2019-05-13
-
Publication No.: US10703733B2Publication Date: 2020-07-07
- Inventor: Hang Chu , Juan A. Guerrero , Anna E. Hurtley , Tae H. Hwang , Lan Jiang , Darryl Kato , Tetsuya Kobayashi , John E. Knox , Scott E. Lazerwith , Xiaofen Li , David W. Lin , Jonathan W. Medley , Michael L. Mitchell , Devan Naduthambi , Zachary Newby , Neil H. Squires , Vickie H. Tsui , Chandrasekar Venkataramani , William J. Watkins , Hong Yang
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D513/08
- IPC: C07D513/08 ; C07D267/20 ; C07D413/12 ; C07D413/14 ; C07D417/12 ; C07D471/04 ; C07D487/04 ; C07D498/04 ; A61K45/06
Abstract:
The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer.
Public/Granted literature
- US20190352271A1 MCL-1 INHIBITORS Public/Granted day:2019-11-21
Information query
